Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Cessation to launch Phase IIa monoclonal antibody trial in opioid abuse
Clinical Trials Arena via Yahoo Finance· 4 days agoCessation Therapeutics will be advancing its investigational monoclonal antibody to a Phase IIa ...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 7 days agoRegeneron has released encouraging trial results for its multiple myeloma antibody, linvoseltamab....
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
Pharmaceutical Technology via Yahoo Finance· 2 days agoLinvoseltamab in RRMM Data from the Phase I/II first-in-human, open-label LINKER-MM1 study...
J&J's phase 2 Sjögren's data support FcRn strategy in the autoimmune disorder
FierceBiotech· 7 days agoJ&J already revealed back in February that its anti-FcRn antibody nipocalimab had scored a win in a...
Study finds new treatment for ulcerative colitis
Medical Xpress· 6 days agoThe medication, guselkumab (Tremfya), is an antibody that blocks IL-23, the cytokine that drives many immune diseases, including ulcerative colitis. The...
Study suggests cancer patients should stay current on COVID-19 boosters
Center for Infectious Disease Research and Policy· 3 days agoShare Copied to clipboard Yesterday in Nature Communications a study shows cancer that patients who...
Beyond the lung: treating the GI symptoms of Covid-19
Pharmaceutical Technology via Yahoo Finance· 6 days agoCovid-19 is more than a respiratory disease, the presence of gastrointestinal (GI) symptoms are an...
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Reuters via AOL· 7 days agoThe drug, an antibody-drug conjugate (ADC), was being studied in a trial sponsored by China-based...
Johnson & Johnson’s nipocalimab shows promise in Sjögren’s disease trial
Clinical Trials Arena via Yahoo Finance· 7 days agoJohnson & Johnson announced findings from the Phase II DAHLIAS dose-ranging study where its...